SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-10-081739
Filing Date
2010-04-13
Accepted
2010-04-12 18:36:41
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM F-1 df1a.htm F-1/A 1671487
2 FORM OF UNDERWRITING AGREEMENT. dex11.htm EX-1.1 157928
3 FORM OF OPINION OF FARRIS, VAUGHN, WILLS & MURPHY, LLP. dex51.htm EX-5.1 6558
4 CONSENT OF PRICEWATERHOUSECOOPERS, LLP. dex231.htm EX-23.1 1886
5 CONSENT OF UNIVERSITY HEALTH NETWORK. dex233.htm EX-23.3 5772
7 GRAPHIC g76857g17w17.jpg GRAPHIC 27983
8 GRAPHIC g76857g23o04.jpg GRAPHIC 29728
9 GRAPHIC g76857g39g29.jpg GRAPHIC 28174
10 GRAPHIC g76857g54a95.jpg GRAPHIC 20001
  Complete submission text file 0001193125-10-081739.txt   1991541
Mailing Address #300 - 2386 EAST MALL GERALD MCGAVIN BUILDING VANCOUVER A1 V6T 1Z3
Business Address #300 - 2386 EAST MALL GERALD MCGAVIN BUILDING VANCOUVER A1 V6T 1Z3 (604) 827-5100
Med BioGene Inc. (Filer) CIK: 0001478455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-164050 | Film No.: 10745826
SIC: 8071 Services-Medical Laboratories